Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Precision BioSciences, Inc. (DTIL) had Receiveable Turnover of 54.08 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$48.73M |
|
$-61.32M |
|
-- |
|
$48.73M |
|
$92.46M |
|
$-43.74M |
|
$1.21M |
|
$-42.53M |
|
$-42.07M |
|
$-42.53M |
|
$-42.53M |
|
$-61.32M |
|
$-42.07M |
|
$-43.74M |
|
$-36.00M |
|
3.84M |
|
3.84M |
|
$-15.96 |
|
$-15.96 |
|
| Balance Sheet Financials | |
$136.36M |
|
$6.34M |
|
$23.42M |
|
$159.78M |
|
$49.99M |
|
-- |
|
$90.93M |
|
$140.92M |
|
$18.86M |
|
$18.46M |
|
$18.86M |
|
4.16M |
|
| Cash Flow Statement Financials | |
$-84.11M |
|
$5.83M |
|
$5.39M |
|
$189.58M |
|
$116.68M |
|
$-72.90M |
|
$14.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-89.76% |
|
-89.76% |
|
-73.87% |
|
-87.28% |
|
-125.84% |
|
$-85.96M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
|
Receiveable Turnover |
54.08 |
6.75 |
|
-225.48% |
|
-230.36% |
|
-26.62% |
|
-225.48% |
|
$4.53 |
|
$-22.38 |
|
$-21.90 |
|